XML 52 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Oct. 02, 2021
Sep. 26, 2020
Oct. 02, 2021
Sep. 26, 2020
Segment Reporting Information [Line Items]        
Revenues $ 9,330 $ 8,521 $ 28,509 $ 21,668
Operating Income 2,278 2,426 7,490 4,723
Cost of revenues charges     (8)  
Selling, general and administrative (charges) credits (59)   (33)  
Restructuring and other costs (18) (17) (151) (67)
Amortization of acquisition-related intangible assets     (1,295) (1,256)
Interest Income 9 9 32 53
Interest Expense (128) (144) (375) (407)
Other Income (Expense) 14 (39) (174) (36)
Income before income taxes 2,173 2,252 6,973 4,333
Life Sciences Solutions [Member]        
Segment Reporting Information [Line Items]        
Cost of revenues charges     (8)  
Selling, general and administrative (charges) credits (23)   24  
Restructuring and other costs 3   (125)  
Analytical Instruments [Member]        
Segment Reporting Information [Line Items]        
Selling, general and administrative (charges) credits (1)   (1)  
Restructuring and other costs (2)   (5)  
Specialty Diagnostics [Member]        
Segment Reporting Information [Line Items]        
Selling, general and administrative (charges) credits     2  
Restructuring and other costs (14)   (17)  
Laboratory Products and Services [Member]        
Segment Reporting Information [Line Items]        
Selling, general and administrative (charges) credits (26)   (49)  
Restructuring and other costs 3   5  
Total Reportable Segments [Member]        
Segment Reporting Information [Line Items]        
Operating Income 2,778 2,803 8,977 6,044
Total Reportable Segments [Member] | Life Sciences Solutions [Member]        
Segment Reporting Information [Line Items]        
Revenues 3,721 3,424 11,481 7,800
Operating Income 1,821 1,879 5,818 3,788
Total Reportable Segments [Member] | Analytical Instruments [Member]        
Segment Reporting Information [Line Items]        
Revenues 1,476 1,336 4,344 3,488
Operating Income 264 171 816 477
Total Reportable Segments [Member] | Specialty Diagnostics [Member]        
Segment Reporting Information [Line Items]        
Revenues 1,362 1,430 4,212 3,376
Operating Income 310 398 983 848
Total Reportable Segments [Member] | Laboratory Products and Services [Member]        
Segment Reporting Information [Line Items]        
Revenues 3,487 3,112 10,667 8,629
Operating Income 383 355 1,360 931
Intersegment Eliminations [Member]        
Segment Reporting Information [Line Items]        
Revenues (716) (781) (2,195) (1,625)
Segment Reconciling Items [Member]        
Segment Reporting Information [Line Items]        
Cost of revenues charges 0 (1) (8) (5)
Selling, general and administrative (charges) credits (59) 55 (33) 7
Restructuring and other costs (18) (17) (151) (67)
Amortization of acquisition-related intangible assets $ (423) $ (414) $ (1,295) $ (1,256)